By Jamie Freed and Sophie Yu SYDNEY/BEIJING (Reuters) – Airlines have boosted January international seat capacity to and from China…
China hotels, travel bookings perk up in boon for COVID-hit services sector
(This Jan. 6 story has been corrected to fix the final paragraph to say 2 billion trips to be made,…
Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval
By Julie Steenhuysen and Deena Beasley (Reuters) -The U.S. Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab…
Eisai files for full FDA approval for Alzheimer’s drug Leqembi
(Reuters) – Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the U.S. Food and…
Hermes expands in Nanjing as luxury industry bets on Chinese return
By Mimosa Spencer PARIS (Reuters) – Birkin bag maker Hermes is opening a new, enlarged store in China’s Nanjing city,…
Reducing inflation top priority for South Asian nations, says India central bank chief
By Nikunj Ohri NEW DELHI (Reuters) -Taming inflation is the top priority for South Asian countries as risks to growth…
Surging recovery bets on China stocks face reality check
By Jason Xue and Tom Westbrook SHANGHAI/SINGAPORE (Reuters) – Chinese investors are doubling down on economic recovery bets, with a…
China expects passenger traffic during Lunar New Year to double from 2022
BEIJING (Reuters) – China expects the total number of passenger trips made by travellers by road, rail, water and flight…
With few entry tests, Southeast Asia may gain most from China’s travel revival
By Xinghui Kok SINGAPORE (Reuters) – Southeast Asia’s tourist economies are set to be leading beneficiaries of China’s scrapping of…
Moderna signs $35 million deal with cancer drug developer CytomX
(Reuters) – Moderna Inc on Thursday announced a $35 million licensing deal with cancer-focused drug developer CytomX Therapeutics to work…